Tetraphase Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Tetraphase Pharmaceuticals Ownership

Who owns Tetraphase Pharmaceuticals?

Tetraphase Pharmaceuticals is owned by La Jolla Pharmaceutical. It was acquired on June 24, 2020.

Was Tetraphase Pharmaceuticals formerly PE-backed?

Yes. Tetraphase Pharmaceuticals was formerly owned by 2 private investors.

Tetraphase Pharmaceuticals Business Overview

Where is Tetraphase Pharmaceuticals headquartered?

Tetraphase Pharmaceuticals is headquartered in Watertown, Massachusetts.

What is Tetraphase Pharmaceuticals’ revenue?

Tetraphase Pharmaceuticals disclosed revenue of 7M USD for 2019 and 19M USD for 2018.

How many employees does Tetraphase Pharmaceuticals have?

Tetraphase Pharmaceuticals has 119 employees.

What sector is Tetraphase Pharmaceuticals in?

Tetraphase Pharmaceuticals is a life science company.

When was Tetraphase Pharmaceuticals founded?

Tetraphase Pharmaceuticals was founded in 2006.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals, Inc.

480 Arsenal Street, Suite 110,
Watertown, Massachusetts 02472
United States,
(617) 715-3600
www.tphase.com

Tetraphase Pharmaceuticals is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening multidrug-resistant (MDR) infections. Tetraphase Pharmaceuticals was founded in 2006 and is based in Watertown, Massachusetts.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.